top of page
MD.jpg

IN THE STATES

MARYLAND

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Maryland in 2022.

MD.png

Economic
Output

$35B

Direct Jobs Supported by the Industry

33,423

Total Jobs Supported

113,664

State Total Vendor Relationships

1,512

State Total Vendor Spending

$1,230,264,825

Clinical
Trials

872

Investments at Clinical Trial Sites

$323.4M

Clinical Trial Participants

19,317

Total Economic Impact of Clinical Trial Sites

$845.7M

bottom of page